Real‐world effectiveness and safety of dupilumab for the treatment of atopic dermatitis in Japanese patients: a single‐centre retrospective study-Reference-Cited by-同舟云学术

Real‐world effectiveness and safety of dupilumab for the treatment of atopic dermatitis in Japanese patients: a single‐centre retrospective study

Published:2019-08-22 Issue:5 Volume:181 Page:1083-1085
ISSN:0007-0963
Container-title:British Journal of Dermatology
language:en
Short-container-title:Br J Dermatol

Author:

Uchida H.¹,Kamata M.¹^ORCID,Mizukawa I.¹,Watanabe A.¹,Agematsu A.¹,Nagata M.¹,Fukaya S.¹,Hayashi K.¹,Fukuyasu A.¹,Tanaka T.¹,Ishikawa T.¹,Ohnishi T.¹,Tada Y.¹^ORCID

Affiliation:

1. Department of Dermatology Teikyo University School of Medicine 2‐11‐1 Kaga, Itabashi‐ku Tokyo 173‐8605 Japan

Publisher

Wiley

Subject

Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjd.18163

Reference4 articles.

1. Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis

2. Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial

3. Dupilumab with concomitant topical corticosteroid treatment in adults with atopic dermatitis with an inadequate response or intolerance to ciclosporin A or when this treatment is medically inadvisable: a placebo-controlled, randomized phase III clinical t

4. Dupilumab Improved Alopecia Areata in a Patient with Atopic Dermatitis: A Case Report

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Atopic dermatitis: treatment and innovations in immunotherapy;Inflammopharmacology;2024-04-06

2. Assessment of long-term safety and efficacy of Dupilumab therapy in patients with moderate-to-severe atopic dermatitis in the UAE: A real-life observational study;PHARM PRACT-GRANADA;2024

3. Real-world effectiveness and safety of baricitinib including its effect on biomarkers and laboratory data in Japanese adult patients with atopic dermatitis: a single-center retrospective study;Journal of Cutaneous Immunology and Allergy;2024-02-23

4. Impact of 1‐year treatment with dupilumab on work productivity in Japanese patients with atopic dermatitis;Experimental Dermatology;2024-02

5. Safety and efficacy of dupilumab in adult atopic dermatitis in Singapore;Singapore Medical Journal;2024-01-08